High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. (Q43626751)
Jump to navigation
Jump to search
scientific article published in June 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. |
scientific article published in June 2001 |
Statements
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis (English)
M D Krailo
M Ladanyi
K W Chan
S L Sailer
P S Dickman
D L Baker
R B Gerbing
A Grovas
C E Herzog
K L Lindsley
W Liu-Mares
J B Nachman
L Sieger